Tissue engineering design of novel bio-therapeutics for cancer treatment

Project Description

Applications are invited for a postgraduate research position leading to a PhD in Biomedical Engineering, with a focus on Tissue Engineering.

Tissue engineering holds significant promise for treating and understanding degenerative ailments, such as osteoarthritis and cardiovascular disease, by designing biological scaffolds using both synthetic biodegradable polyesters and naturally occurring extracellular matrix materials.

Cancer is one of the most prevalent diseases worldwide, and this research aims to develop a tissue-engineered scaffold to assist in cancer treatment. The goal of the project is to create scaffolds that support tumor suppression and microenvironment recovery.

The project will be conducted at the Institute for Bioengineering (IBioE). The student will acquire skills in biomaterial design, fabrication, characterization, and cell culture, utilizing techniques such as scanning electron microscopy, nano-indentation, mechanical property testing, ELISA, and real-time RT-PCR. These skills are essential for pursuing industrial careers in the biomedical sector and are valuable for an academic career in Tissue Engineering/Biomedical Engineering.

Further Information: 

Dr. Callanan - Google Scholar Profile

Dr. Callanan - Edinburgh University Profile

Minimum entry qualification - To undertake this research, we are seeking a motivated candidate with an honors degree at 2:1 or above in any of these areas, chemical engineering, chemistry, materials science, physics, mechanical engineering, biomedical engineering, synthetic chemistry, organic chemistry, biochemistry, molecular biology or a related discipline.

Further information on English language requirements for EU/Overseas applicants.

Applications are welcomed from self-funded students, or students who are applying for  scholarships from the University of Edinburgh or elsewhere

Competition funding opportunities available – please enquire

Further information and other funding options.